Agendia Publishes Compelling First Independent Validation Study Of Colon Cancer Recurrence Test "ColoPrint" In Journal Of Clinical Oncology
IRVINE, California and AMSTERDAM, December 15, 2010 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, announced today that together with principal investigators from Spain, the…